Search Results - Mora-Rillo, M
-
1
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy.
Article | by Ferreras, C; Pascual-Miguel, B; Mestre-Duran, C; Navarro-Zapata, A; Clares-Villa, L; Martin-Cortazar, C; De Paz, R; Marcos, A; Vicario, JL; Balas, A; Garcia-Sanchez, F; Eguizabal, C; Solano, C; Mora-Rillo, M; Soria, B; Perez-Martinez, A | Published 2021 |Other Authors: “…Mora-Rillo, M…”
-
2
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy.
Article | by Ferreras C; Pascual-Miguel B; Mestre-Durán C; Navarro-Zapata A; Clares-Villa L; Martín-Cortázar C; De Paz R; Marcos A; Vicario JL; Balas A; García-Sánchez F; Eguizabal C; Solano C; Mora-Rillo M; Soria B; Pérez-Martínez A | Published 2021 |Other Authors: “…Mora-Rillo M…”
-
3
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Article | by Navarro-San Francisco, C.; Mora-Rillo, M.; Romero-Gómez, M.P.; Moreno-Ramos, F.; Rico-Nieto, A.; Ruiz-Carrascoso, G.; Gómez-Gil, R.; Arribas-López, J.R.; Mingorance, J.; Paño-Pardo, J.R. | Published 2013 |Other Authors: “…Mora-Rillo, M.…”
-
4
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms
Article | by Temkin, E; Torre-Cisneros, J; Beovic, B; Benito, N; Giannella, M; Gilarranz, R; Jeremiah, C; Loeches, B; Machuca, I; Jimenez-Martin, MJ; Martinez, JA; Mora-Rillo, M; Navas, E; Osthoff, M; Pozo, JC; Ramos, JCR; Rodriguez, M; Sanchez-Garcia, M; Viale, P; Wolff, M; Carmeli, Y | Published 2017 |Other Authors: “…Mora-Rillo, M…”
-
5
Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
Article | by Pano-Pardo, José Ramón; Ruiz-Carrascoso, G.; Navarro-San Francisco, C.; Gomez-Gil, R.; Mora-Rillo, M.; Romero-Gomez, M. P.; Fernandez-Romero, N.; Garcia-Rodriguez, J.; Perez-Blanco, V.; Moreno-Ramos, F.; Mingorance, J. | Published 2013 |Other Authors: “…Mora-Rillo, M.…”
-
6
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
Article | by Perez-Martinez, A; Mora-Rillo, M; Ferreras, C; Guerra-Garcia, P; Pascual-Miguel, B; Mestre-Duran, C; Borobia, A M; Carcas, A J; Queiruga-Parada, J; Garcia, I; Sanchez-Zapardiel, E; Gasior, M; De Paz, R; Marcos, A; Vicario, J L; Balas, A; Moreno, M A; Eguizabal, C; Solano, C; Arribas, J R; Buckley, R de Miguel; Montejano, R; Soria, B | Published 2021 |Other Authors: “…Mora-Rillo, M…”
-
7
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum ß-lactamase-producing Enterobacteriaceae
Article | by Russo, A; Falcone, M; Gutiérrez-Gutiérrez, B; Calbo, E; Almirante, B; Viale, PL; Oliver, A; Ruiz-Garbajosa, R; Gasch, O; Gozalo, M; Pitout, J; Akova, M; Peña, C; Cisneros, JM; Hernández-Torres, A; Farcomeni, A; Prim, N; Origün, J; Bou, G; Tacconelli, E; Tumbarello, M; Hamprecht, A; Karaiskos, I; de la Calle, C; Pérez, F; Schwaber, MJ; Bermejo, J; Lowman, W; Hsueh, RR; Mora-Rillo, M; Rodriguez-Gomez, J; Souli, M; Bonomo, RA; Paterson, DL; Carmeli, Y; Pascual, A; Rodríguez-Baño, J; Venditti, M | Published 2018 |Other Authors: “…Mora-Rillo, M…”
-
8
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum beta-lactamase-producing Enterobacteriaceae
Article | by Russo, A; Falcone, M; Gutierrez-Gutierrez, B; Calbo, E; Almirante, B; Viale, PL; Oliver, A; Ruiz-Garbajosa, R; Gasch, O; Gozalo, M; Pitout, J; Akova, M; Pena, C; Cisneros, JM; Hernandez-Torres, A; Farcomeni, A; Prim, N; Origun, J; Bou, G; Tacconelli, E; Tumbarello, M; Hamprecht, A; Karaiskos, I; de la Calle, C; Perez, F; Schwaber, MJ; Bermejo, J; Lowman, W; Hsueh, RR; Mora-Rillo, M; Rodriguez-Gomez, J; Souli, M; Bonomo, RA; Paterson, DL; Carmeli, Y; Pascual, A; Rodriguez-Bano, J; Venditti, M | Published 2018 |Other Authors: “…Mora-Rillo, M…”
-
9
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
Article | by Pérez-Martínez A; Mora-Rillo M; Ferreras C; Guerra-García P; Pascual-Miguel B; Mestre-Durán C; Borobia AM; Carcas AJ; Queiruga-Parada J; García I; Sánchez-Zapardiel E; Gasior M; De Paz R; Marcos A; Vicario JL; Balas A; Moreno MA; Eguizabal C; Solano C; Arribas JR; Buckley RM; Montejano R; Soria B | Published 2021 |Other Authors: “…Mora-Rillo M…”
-
10
A Multinational, Preregistered Cohort Study of ß-Lactam/ß-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-ß-Lactamase-Producing <i...
Article | by Gutiérrez-Gutiérrez, B; Pérez-Galera, S; Salamanca, E; de Cueto, M; Calbo, E; Almirante, B; Viale, P; Oliver, A; Pintado, V; Gasch, O; Martínez-Martínez, L; Pitout, J; Akova, M; Peña, C; Molina, J; Hernández, A; Venditti, M; Prim, N; Origüen, J; Bou, G; Tacconelli, E; Tumbarello, M; Hamprecht, A; Giamarellou, H; Almela, M; Pérez, F; Schwaber, MJ; Bermejo, J; Lowman, W; Hsueh, PR; Mora-Rillo, M; Natera, C; Souli, M; Bonomo, RA; Carmeli, Y; Paterson, DL; Pascual, A; Rodríguez-Baño, J | Published 2016 |Other Authors: “…Mora-Rillo, M…”